Page last updated: 2024-10-31

deoxyepinephrine and Disease Exacerbation

deoxyepinephrine has been researched along with Disease Exacerbation in 6 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Research Excerpts

ExcerptRelevanceReference
"An ibopamine challenge is a novel technique for assessing glaucoma using ibopamine, a topical drug which temporarily increases aqueous production."9.20Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases. ( Craig, JE; Landers, J; Ullrich, K, 2015)
"A glaucoma patient with a positive ibopamine challenge will show a negative challenge result when re-tested following trabeculectomy surgery."5.22Ibopamine challenge testing becomes negative following successful trabeculectomy surgery. ( Craig, JE; Landers, J; Ullrich, K, 2016)
"An ibopamine challenge is a novel technique for assessing glaucoma using ibopamine, a topical drug which temporarily increases aqueous production."5.20Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases. ( Craig, JE; Landers, J; Ullrich, K, 2015)
" The patients were randomly divided into two groups: 96 took ibopamine at a dosage of 100 mg/day (group A) and 93 served as controls (group B)."2.68Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial. ( Bazzato, G; Bignamini, AA; Bonomini, M; Bonomini, V; Brancaccio, D; Cappelli, P; Cossu, M; De Biase, V; Docci, D; Fanciulli, E; Feletti, C; Fracasso, A; Galmozzi, C; La Manna, G; Locatelli, F; Marai, P; Mioli, V; Mosconi, G; Oldrizzi, L; Piccoli, G; Roccatello, D; Scarpioni, L; Sorba, GB; Stefoni, S; Sverzellati, E, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Landers, J2
Ullrich, K2
Craig, JE2
Salvetat, ML1
Zeppieri, M1
Tosoni, C1
Brusini, P1
Petrie, CJ1
Voors, AA1
van Veldhuisen, DJ2
Brouwer, J1
Man in 't Veld, AJ1
Dunselman, PH1
Boomsma, F1
Lie, KI1
Stefoni, S1
Mosconi, G1
La Manna, G1
Bonomini, V1
Mioli, V1
Fanciulli, E1
Feletti, C1
Docci, D1
Cappelli, P1
Bonomini, M1
Locatelli, F1
Marai, P1
Bazzato, G1
Fracasso, A1
Brancaccio, D1
Galmozzi, C1
Scarpioni, L1
Sverzellati, E1
Sorba, GB1
Cossu, M1
Piccoli, G1
Roccatello, D1
Oldrizzi, L1
De Biase, V1
Bignamini, AA1

Trials

5 trials available for deoxyepinephrine and Disease Exacerbation

ArticleYear
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
    Clinical & experimental ophthalmology, 2015, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma;

2015
Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
    Clinical & experimental ophthalmology, 2016, Volume: 44, Issue:3

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Deoxyepinephrine; Disease Progression; Dopamine Ag

2016
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
    International journal of cardiology, 2009, Jan-24, Volume: 131, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine;

2009
Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
    The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12

    Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Disease

1995
Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial.
    American journal of nephrology, 1996, Volume: 16, Issue:6

    Topics: Adolescent; Aged; Creatinine; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Huma

1996

Other Studies

1 other study available for deoxyepinephrine and Disease Exacerbation

ArticleYear
Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Eye (London, England), 2016, Volume: 30, Issue:6

    Topics: Aged; Deoxyepinephrine; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans

2016